| Literature DB >> 29402762 |
Jenny Vilchis-Gil1, Miguel Klünder-Klünder1,2, Samuel Flores-Huerta1.
Abstract
BACKGROUND: Obesity is a chronic low-intensity state of inflammation with metabolic alterations that, when acquired during childhood, lead to severe illness in adults. Encouraging healthy eating habits and physical activity is the basis for preventing and treating obesity and its complications.Entities:
Keywords: biomarkers; child; early intervention (education); insulin resistance; obesity
Mesh:
Substances:
Year: 2018 PMID: 29402762 PMCID: PMC5818679 DOI: 10.2196/jmir.9052
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Study population.
Baseline characteristics of the study population (n=315).
| Characteristic | Control (n=128) | Intervention (n=187) | |||
| Age in years, mean (SD) | 8.1 (1.2) | 7.9 (1.2) | .26 | ||
| Sex (female), n (%) | 70 (54.7) | 85 (45.5) | .11 | ||
| Weight (kg)b | 30.4 (5.0) | 29.7 (5.0) | .26 | ||
| Height (cm)b | 127.5 (7.1) | 126.6 (7.1) | .30 | ||
| Body mass index (BMI) | 1.07 (1.3) | 0.94 (1.4) | .41 | ||
| Normal weight ( | 61 (47.7) | 99 (52.9) | |||
| Overweight ( | 31 (24.2) | 47 (25.1) | |||
| Obesity ( | 36 (28.1) | 41 (21.9) | .44 | ||
| Middle school or less | 15 (12.1) | 34 (19.4) | |||
| High school or technical school | 55 (44.4) | 67 (38.3) | |||
| College career or postgraduate | 54 (43.5) | 74 (42.3) | .22 | ||
| Public | 63 (49.2) | 112 (59.9) | |||
| Private | 65 (50.8) | 75 (40.1) | .06 | ||
aP value according to Student´s t test and χ2 test.
bMeans adjusted by age and sex.
cWorld Health Organization standard, 2007.
Metabolic parameters by study group at baseline.
| Parameter | Control (n=128) | Intervention (n=187) | |
| Glucose (mg/dL) | 87 (82-93) | 85 (81-90) | .03 |
| Triglycerides (mg/dL) | 67 (54-90) | 73 (49-102) | .32 |
| Total cholesterol (mg/dL) | 155 (143-175) | 170 (150-185) | .001 |
| LDL-Cb (mg/dL) | 92.9 (81.7-110.3) | 103.0 (85.4-117.4) | .03 |
| HDL-Cc (mg/dL) | 47 (39-55) | 50 (41-57) | .15 |
| Insulin (μU/mL) | 2.6 (1.9-5.1) | 3.8 (2.2-6.6) | .001 |
| HOMA-IRd | 0.53 (0.43-1.21) | 0.79 (0.46-1.39) | .005 |
aP-value according Mann-Whitney U test.
bLDL-C: low-density lipoprotein cholesterol.
cHDL-C: high-density lipoprotein cholesterol.
dHOMA-IR: homeostasis model to assess the insulin resistance index.
Change in metabolic parameters from baseline to 12 months.
| Parametera | Control (n=74) | Intervention (n=119) | Intervention effect, model 1, β (95% CI)c | Intervention effect, model 2, β (95% CI)d | |||
| Glucose (mg/dL) | 4.86 (3.84 to 5.88) | 3.38 (2.79 to 3.98) | -1.53 (–2.66 to –0.40) | .008 | –1.83 (–3.06 to –0.60) | .004 | |
| Triglycerides (mg/dL) | 2.25 (–1.16 to 5.67) | –6.74 (–9.20 to –4.29) | -5.76 (-9.90 to -1.62) | .007 | -5.25 (–1.46 to 0.97) | .01 | |
| Total cholesterol (mg/dL) | 1.76 (–1.10 to 4.62) | -2.54 (–6.38 to 1.31) | -3.36 (–6.66 to –0.05) | .046 | -3.22 (–7.11 to 0.67) | .10 | |
| LDL-C (mg/dL) | 1.10 (–1.74 to 3.93) | -1.62 (–3.96 to 0.72) | -2.56 (–4.89 to –0.22) | .03 | -2.59 (–5.12 to –0.06) | .045 | |
| HDL-C (mg/dL) | -0.47 (–1.31 to 0.37) | -0.14 (–0.74 to 0.49) | 0.55 (–0.54 to 1.63) | .32 | 0.36 (–0.73 to 1.45) | .52 | |
| Insulin (μU/mL) | 1.30 (0.60 to 1.99) | –0.09 (–0.29 to 0.11) | –0.97 (–1.54 to –0.40) | .001 | -0.84 (–1.31 to –0.37) | .001 | |
| HOMA-IR | 0.37 (0.16 to 0.58) | 0.03 (–0.01 to 0.06) | -0.22 (–0.34 to –0.11) | <.001 | –0.21 (–0.32 to –0.09) | .001 |
aLDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostasis model to assess the insulin resistance index.
bChange from baseline at 12 months, adjusted for baseline data of the dependent variable, baseline age, and sex.
cQuantile regression models, adjusted for baseline data of the dependent variable, baseline age, sex, and public and private school.
dQuantile regression models, adjusted for baseline data of the dependent variable, baseline age, sex, public and private school, and baseline BMI z-score.
Figure 2Change of baseline at 12 months in the homeostasis model assessment-estimated insulin resistance (HOMA-IR) and the relationship with body mass index (BMI) z-score baseline in the groups.